Basics Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 3.52% Avg Daily Range (30 D): $0.43 | 3.21% Avg Daily Range (90 D): $0.35 | 3.16% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): 1.52M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 1,797 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $2.14M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.85M Avg Closing Trade (30 D): $2.87M Avg Closing Trade (90 D): $1.65M Avg Closing Volume: 109K     News Dec 6, 2025 @ 2:30 PM Nurix Therapeutics Presents New Data Demonstrating... Source: Nurix Therapeutics Dec 1, 2025 @ 12:00 PM Nurix Therapeutics Announces Webcast to Review New... Source: Nurix Therapeutics Nov 3, 2025 @ 2:00 PM Nurix Therapeutics Announces Presentations at the ... Source: Nurix Therapeutics Oct 27, 2025 @ 11:00 AM Nurix Therapeutics Announces Closing of $250.0 Mil... Source: Nurix Therapeutics, Inc. Oct 22, 2025 @ 10:00 AM Nurix Initiates DAYBreakâ„¢ Pivotal Study of B... Source: Nurix Therapeutics, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.03 $-.52 Diluted EPS $-1.03 $-.52 Revenue $ $ 7.89M $ 44.06M Gross Profit $ $ $ Net Income / Loss $ $ -86.42M $ -43.46M Operating Income / Loss $ $ -91.39M $ -48.32M Cost of Revenue $ $ $ Net Cash Flow $ $ -5.76M $ 8.34M PE Ratio